PRODUCTS
SERVICES
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
1.99
2 yrs 8 m
1%
2,158.58 Crs
1% on or before 30D, Nil after 30D
Mid Growth
7.84
SIP 100 & Lumpsum 100
BSE HEALTH CARE - TRI
Nikhil Mathur
Investors understand that their principal will be at very high risk